osimertinib
astrazeneca
['adaura', 'osimertinib', 'nsclc', 'sclc', 'aura ,(-laura)']
updated results from adaura study: osimertinib is a highly effective treatment for patients with resectable stage ib iiia egfr-mutated nsclc #esmo2022 #esmo22 
BAL’98 //EÜTF’04 // MD & Founder @misPHARMA // Medical Director & Board Member @RS_Research_TR